39103 Search Results


90
ATCC bacillus amyloliquefaciens subsp plantarum ucmb5036
Bacillus Amyloliquefaciens Subsp Plantarum Ucmb5036, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bacillus amyloliquefaciens subsp plantarum ucmb5036/product/ATCC
Average 90 stars, based on 1 article reviews
bacillus amyloliquefaciens subsp plantarum ucmb5036 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
ATCC a protophormiae
A Protophormiae, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a protophormiae/product/ATCC
Average 90 stars, based on 1 article reviews
a protophormiae - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

93
Addgene inc bd4
(A) Coomassie gel of the purified recombinant proteins BD2, BD3, <t>BD4,</t> BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .
Bd4, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bd4/product/Addgene inc
Average 93 stars, based on 1 article reviews
bd4 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology shrna jnk3 plasmid
( A ) Western blot analysis detected Jnk (Jnk1/Jnk2) expression in SP600125-induced tetraploid cells and normal diploid cells. Error bars represent the means ± SD; n = 3. P < 0.001. ( B ) <t>shRNA</t> knockdown of <t>jnk1/jnk3</t> . Cells transfected with an empty vector were used as control. Knockdown was evaluated by Q-PCR. Expression values are relative to actin expression on set as 1. Error bars represent the means ± SD; n = 3. P < 0.001. ( C ) FACS analysis of jnk1 -shRNA (blue) and jnk3 -shRNA (green) transfected cell DNA content. An empty vector (red) was transfected as the control.
Shrna Jnk3 Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/shrna jnk3 plasmid/product/Santa Cruz Biotechnology
Average 91 stars, based on 1 article reviews
shrna jnk3 plasmid - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

Image Search Results


(A) Coomassie gel of the purified recombinant proteins BD2, BD3, BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .

Journal: bioRxiv

Article Title: PBRM1-Dependent PBAF Targeting is Required for EMT and Metastasis in Breast Cancer

doi: 10.1101/2025.10.19.683137

Figure Lengend Snippet: (A) Coomassie gel of the purified recombinant proteins BD2, BD3, BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .

Article Snippet: Constructs encoding codon-optimized ORFs for bacterial expression of human PBRM1 BD2 (addgene #39013), BD3 (addgene #39030), BD4 (addgene #39103), BD5 (addgene #38999) and tandem BD2-5 (SGC construct ID #PB1A-c080) were transformed in BL21(DE3) for BDs, and BL21 Rosetta2 (DE3) pLysS for tandem BD2-5.

Techniques: Purification, Recombinant, Binding Assay, Positive Control, ChIP-sequencing

( A ) Western blot analysis detected Jnk (Jnk1/Jnk2) expression in SP600125-induced tetraploid cells and normal diploid cells. Error bars represent the means ± SD; n = 3. P < 0.001. ( B ) shRNA knockdown of jnk1/jnk3 . Cells transfected with an empty vector were used as control. Knockdown was evaluated by Q-PCR. Expression values are relative to actin expression on set as 1. Error bars represent the means ± SD; n = 3. P < 0.001. ( C ) FACS analysis of jnk1 -shRNA (blue) and jnk3 -shRNA (green) transfected cell DNA content. An empty vector (red) was transfected as the control.

Journal: Scientific Reports

Article Title: Autotetraploid cell Line induced by SP600125 from crucian carp and its developmental potentiality

doi: 10.1038/srep21814

Figure Lengend Snippet: ( A ) Western blot analysis detected Jnk (Jnk1/Jnk2) expression in SP600125-induced tetraploid cells and normal diploid cells. Error bars represent the means ± SD; n = 3. P < 0.001. ( B ) shRNA knockdown of jnk1/jnk3 . Cells transfected with an empty vector were used as control. Knockdown was evaluated by Q-PCR. Expression values are relative to actin expression on set as 1. Error bars represent the means ± SD; n = 3. P < 0.001. ( C ) FACS analysis of jnk1 -shRNA (blue) and jnk3 -shRNA (green) transfected cell DNA content. An empty vector (red) was transfected as the control.

Article Snippet: Jnk shRNA lentiviral vector plasmids (shRNA jnk1 Plasmid (m): sc-29381-SH; and shRNA jnk3 Plasmid (m): sc-39104) was purchased from Santa Cruz (UK) and the three shRNAs were pooled.

Techniques: Western Blot, Expressing, shRNA, Knockdown, Transfection, Plasmid Preparation, Control